Cargando…

Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease

BACKGROUND: Parkinson’s disease (PD) is associated with cognitive decline through multiple mechanisms, including Alzheimer’s disease (AD) pathology and cortical Lewy body involvement. However, its underlying mechanisms remain unclear. Recently, AD-related plasma biomarkers have emerged as potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizutani, Yasuaki, Ohdake, Reiko, Tatebe, Harutsugu, Higashi, Atsuhiro, Shima, Sayuri, Ueda, Akihiro, Ito, Mizuki, Tokuda, Takahiko, Watanabe, Hirohisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576723/ https://www.ncbi.nlm.nih.gov/pubmed/37480401 http://dx.doi.org/10.1007/s00415-023-11875-z

Ejemplares similares

Enzymatic properties and clinical associations of serum alpha‐galactosidase A in Parkinson's disease
por: Mizutani, Yasuaki, et al.
Publicado: (2023)

Multiple System Atrophy: Advances in Diagnosis and Therapy
por: Watanabe, Hirohisa, et al.
Publicado: (2023)

Characteristics of Neural Network Changes in Normal Aging and Early Dementia
por: Watanabe, Hirohisa, et al.
Publicado: (2021)

Long-term response to immunotherapy in patients with hypertrophic pachymeningitis
por: Senda, Mayumi, et al.
Publicado: (2023)

Fatigue evaluated using the 16-item Parkinson Fatigue Scale (PFS-16) predicts Parkinson’s disease prognosis
por: Niimi, Yoshiki, et al.
Publicado: (2019)

Magnetic Resonance Neurography in a Patient with Distal Neuralgic Amyotrophy
por: Nagao, Ryunosuke, et al.
Publicado: (2020)

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer’s disease and down syndrome
por: Tatebe, Harutsugu, et al.
Publicado: (2017)

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference
por: Ishii, Ryotaro, et al.
Publicado: (2015)

The domestic cat as a natural animal model of Alzheimer’s disease
por: Chambers, James K., et al.
Publicado: (2015)

Biomarker repurposing: Therapeutic drug monitoring of serum theophylline offers a potential diagnostic biomarker of Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2018)

Cerebral spinal fluid biomarker profiles in CNS infection associated with HSV and VZV mimic patterns in Alzheimer’s disease
por: Shinomoto, Makiko, et al.
Publicado: (2021)

Differential Expression of Alpha-Synuclein in Hippocampal Neurons
por: Taguchi, Katsutoshi, et al.
Publicado: (2014)

p62/SQSTM1-Dependent Autophagy of Lewy Body-Like α-Synuclein Inclusions
por: Watanabe, Yoshihisa, et al.
Publicado: (2012)

Quantification of Blood Caffeine Levels in Patients With Parkinson's Disease and Multiple System Atrophy by Caffeine ELISA
por: Ohmichi, Takuma, et al.
Publicado: (2020)

Serum Levels of Coenzyme Q10 in Patients with Multiple System Atrophy
por: Kasai, Takashi, et al.
Publicado: (2016)

Monoclonal antibody with conformational specificity for a toxic conformer of amyloid β42 and its application toward the Alzheimer’s disease diagnosis
por: Murakami, Kazuma, et al.
Publicado: (2016)

Visuoperceptual disturbances in Parkinson's disease
por: Kawabata, Kazuya, et al.
Publicado: (2020)

Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson’s disease
por: Yoneyama, Noritaka, et al.
Publicado: (2018)

Connectivity impairment of cerebellar and sensorimotor connector hubs in Parkinson’s disease
por: Bagarinao, Epifanio, et al.
Publicado: (2022)

Changes in Serial D-Dimer Levels Predict the Prognoses of Trousseau's Syndrome Patients
por: Ito, Shinji, et al.
Publicado: (2018)

A Patient With Thiamine Deficiency Exhibiting Muscle Edema Suggested by MRI
por: Murate, Kenichiro, et al.
Publicado: (2018)

Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019)

Proteomic Profiling of Extracellular Vesicles Separated from Plasma of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy
por: Muraoka, Satoshi, et al.
Publicado: (2021)

Nemaline Myopathy Initially Diagnosed as Right Heart Failure with Type 2 Respiratory Failure
por: Ito, Mizuki, et al.
Publicado: (2021)

Increased levels of plasma total tau in adult Down syndrome
por: Kasai, Takashi, et al.
Publicado: (2017)

Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy
por: Muraoka, Satoshi, et al.
Publicado: (2019)

Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease
por: Lim, Nicholas S., et al.
Publicado: (2016)

Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
por: Kasai, Takashi, et al.
Publicado: (2019)

Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics
por: Kojima, Yuta, et al.
Publicado: (2021)

Comparative examination of the pons and corpus callosum as reference regions for quantitative evaluation in positron emission tomography imaging for Alzheimer’s disease using (11)C-Pittsburgh Compound-B
por: Tada, Tomohiro, et al.
Publicado: (2023)

Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis
por: Ikenaka, Kensuke, et al.
Publicado: (2022)

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
por: Nagatsu, Toshiharu, et al.
Publicado: (2022)

Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
por: Imamura, Keiko, et al.
Publicado: (2022)

Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer’s Disease: A PET (THK5351, PiB) and Resting fMRI Study
por: Yokoi, Takamasa, et al.
Publicado: (2018)

Rat umbilical cord blood cells attenuate hypoxic–ischemic brain injury in neonatal rats
por: Nakanishi, Keiko, et al.
Publicado: (2017)

Plasma α-synuclein predicts cognitive decline in Parkinson’s disease
por: Lin, Chin-Hsien, et al.
Publicado: (2017)

Longitudinal analysis of premotor anthropometric and serological markers of Parkinson’s disease
por: Yokoi, Katsunori, et al.
Publicado: (2020)

Progression of Cognitive Decline in Parkinson’s Disease
por: Roheger, Mandy, et al.
Publicado: (2018)

Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases
por: Iriyama, Chisako, et al.
Publicado: (2023)

Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease‐related declines
por: Thomas, Kelsey R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_llh0nfm4q74t4h20khhdp7ssne